Back to today’s briefing

Story perspectives

Denmark's Zealand Pharma Seeks Partner for Obesity Therapy

2/21/2025

43 9

Summary

Story summary

Denmark's Zealand Pharma is on the hunt for a partner for its obesity therapy, petrelintide, as it navigates regulatory hurdles and a growing net loss. CEO Adam Steensberg remains optimistic, prioritizing long-term collaborations. The company’s ability to secure $1 billion for its obesity pipeline showcases unwavering investor confidence in its potential.

1 of 1

Story summary

Denmark's Zealand Pharma is on the hunt for a partner for its obesity therapy, petrelintide, as it navigates regulatory hurdles and a growing net loss. CEO Adam Steensberg remains optimistic, prioritizing long-term collaborations. The company’s ability to secure $1 billion for its obesity pipeline showcases unwavering investor confidence in its potential.